Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 9/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | GRK2 | P25098 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Betaine SCHEMBL1325509 | 0.90 | TSHR (0.38) | BBOX1ALDH1A1TSHRLMNA | |
| SCHEMBL918271 | 0.80 | BBOX1 (0.46) | BBOX1LMNAAPP | |
| SCHEMBL23794900 | 0.80 | EPHX2 (0.38) | ALDH1A1TSHRENPP2 | |
| SCHEMBL14772124 | 0.79 | BBOX1 (0.58) | BBOX1ALDH1A1TSHRMEN1LMNA | |
| SCHEMBL14608930 | 0.79 | ACHE (0.52) | BBOX1ALDH1A1MEN1LMNAPOLB | |
| SCHEMBL18088312 | 0.79 | BBOX1 (0.40) | BBOX1MEN1LMNAPOLBGRK2 | |
| SCHEMBL31143354 | 0.78 | BBOX1 (0.30) | BBOX1 | |
| SCHEMBL5707749 | 0.78 | APP (0.41) | ALDH1A1TSHRLMNAAPP | |
| Acrylamide SCHEMBL3890433 | 0.78 | DNM1 (0.36) | BBOX1ALDH1A1TSHRMEN1LMNA | |
| SCHEMBL9408649 | 0.77 | HTT (0.50) | BBOX1ALDH1A1TSHRKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260034240-A1 | MULTIFUNCTIONAL CREAM HYDROGELS FOR POSTOPERATIVE ADHESION PREVENTION | UNIV NEBRASKA (US) | 2026-02-05 | — | — | US | claimed |
| WO-2024040035-A2 | MULTIFUNCTIONAL CREAM HYDROGELS FOR POSTOPERATIVE ADHESION PREVENTION | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 2024-02-22 | — | — | WO | claimed |
| US-20260034240-A1 | MULTIFUNCTIONAL CREAM HYDROGELS FOR POSTOPERATIVE ADHESION PREVENTION | UNIV NEBRASKA (US) | 2026-02-05 | — | — | US | disclosed |
| WO-2024040035-A2 | MULTIFUNCTIONAL CREAM HYDROGELS FOR POSTOPERATIVE ADHESION PREVENTION | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 2024-02-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034240-A1 | MULTIFUNCTIONAL CREAM HYDROGELS FOR POSTOPERATIVE ADHESION PREVENTION | CDH1, EPCAM, ILK | BBOX1 229/4885ALDH1A1 434/4885TSHR 4561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.